BESREMI (ropeginterferon alfa-2b-njft)
INTERFERON ALFA · POLYCYTHEMIA VERA ·+1
PHARMAESSENTIA
Drug class
Interferon Alfa
Interferon alfa is a class of biological immunomodulating and antineoplastic agents consisting of natural or recombinant cytokines produced in response to viral infections and other immune stimuli. Read more about Interferon Alfa
5 drugs in this class 3 manufacturers
Drugs in Interferon Alfa
PEGASYS (peginterferon alfa-2a)
INTERFERON ALFA · CHRONIC HEPATITIS B ·+4
ZR PHARMA& GMBH
PEGASYS (peginterferon alfa-2a)
INTERFERON ALFA · CHRONIC HEPATITIS B ·+4
ZR PHARMA& GMBH
ALFERON N (interferon alfa-n3)
INTERFERON ALFA · CONDYLOMATA ACUMINATA
HEMBIO-AIM
BESREMI PEN (ropeginterferon alfa-2b-njft)
INTERFERON ALFA · POLYCYTHEMIA VERA ·+1
PHARMAESSENTIA
Filter & compare in the drug finder →
Opens the drug finder with Interferon Alfa preselected. Add indication or manufacturer filters there.
Interferon alfa is a class of biological immunomodulating and antineoplastic agents consisting of natural or recombinant cytokines produced in response to viral infections and other immune stimuli.
These agents bind to specific cell-surface receptors to induce the expression of interferon-stimulated genes, which elicit antiproliferative, direct antiviral, and immune-enhancing effects, such as augmenting cytotoxicity and natural killer cell activity.
Clinically, interferon alfa formulations—including recombinant and pegylated variants—are utilized in the treatment of chronic viral infections, notably chronic hepatitis B and C.
They are also indicated across oncology and hematology to manage conditions such as hairy cell leukemia, malignant melanoma, Kaposi sarcoma, and certain myeloproliferative disorders like polycythemia vera.
-
cancer.gov
Interferon alfa is a class of biological immunomodulating and antineoplastic agents consisting of natural or recombinant cytokines produced in response to viral infections and other immune stimuli These agents bind to specific cell-surface receptors to induce the expression of interferon-stimulated genes, which elicit antiproliferative, direct antiviral, and immune-enhancing effects, such as augmenting cytotoxicity and natural killer cell activity
-
medlineplus.gov
Clinically, interferon alfa formulations—including recombinant and pegylated variants—are utilized in the treatment of chronic viral infections, notably chronic hepatitis B and C
-
cancer.gov
Clinically, interferon alfa formulations—including recombinant and pegylated variants—are utilized in the treatment of chronic viral infections, notably chronic hepatitis B and C Clinically, interferon alfa formulations—including recombinant and pegylated variants—are utilized in the treatment of chronic viral infections, notably chronic hepatitis B and C. They are also indicated across oncology and hematology to manage conditions such as hairy cell leukemia, malignant melanoma, Kaposi sarcoma, ...
-
fda.gov
Clinically, interferon alfa formulations—including recombinant and pegylated variants—are utilized in the treatment of chronic viral infections, notably chronic hepatitis B and C. They are also indicated across oncology and hematology to manage conditions such as hairy cell leukemia, malignant melanoma, Kaposi sarcoma, and certain myeloproliferative disorders like polycythemia vera
-
drugs.com
Clinically, interferon alfa formulations—including recombinant and pegylated variants—are utilized in the treatment of chronic viral infections, notably chronic hepatitis B and C. They are also indicated across oncology and hematology to manage conditions such as hairy cell leukemia, malignant melanoma, Kaposi sarcoma, and certain myeloproliferative disorders like polycythemia vera
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.